do glp 1 affect liver Mechanisms and possible hepatoprotective effects of glucagon-like peptide-1 receptor agonists and other incretin receptor agonists in non-alcoholic fatty disease Multiple target tissue effects of
Description
GLP-1 receptor agonists, originally developed for managing type 2 diabetes, have rapidly emerged as highly effective treatment options for obesity

Roco Salas-Whalen, board-certified in Obesity Medicine

35 Under normal circumstances, islet beta-cell morphology is characterised by a large and stable number of intracellular mature insulin vesicles, which is sustained through the balance between biosynthesis, degradation and secretion

[DOI] [PMC free article] [PubMed] [Google Scholar] 76.Bucinskaite V, Kurosawa M, Miyasaka K, Funakoshi A, Lundeberg T

Funding This work was supported by NSFC (81770776
